Trends in Molecular Medicine
Volume 11, Issue 9, September 2005, Pages 403-411
Journal home page for Trends in Molecular Medicine

Interferon gene regulation: not all roads lead to Tolls

https://doi.org/10.1016/j.molmed.2005.07.006Get rights and content

Many infectious agents elicit a type I interferon response but, until recently, the molecular details that coordinate interferon (IFN)-α and -β expression during infection were unknown. Innate immune pattern recognition receptors, including Toll-like receptors and cytoplasmic RNA helicases such as retinoic acid-inducible gene, that sense viral nucleic acids have been discovered. Using distinct mechanisms, these receptors trigger cellular signaling pathways, culminating in the activation of interferon regulatory factors that transcriptionally induce IFN-α and IFN-β genes.

Section snippets

Key breakthroughs in interferon gene regulation and antiviral sensing

Successful host defense against virus infection relies on early detection followed by the rapid production of type I interferons (IFNs), including multiple IFN-αs and IFN-βs [1]. We now understand in great detail how IFN-α and -β signal and elicit antiviral responses. By contrast, until recently, the knowledge of how viruses are detected during infection and how type I IFN genes are induced was limited. Several key discoveries have now been made which greatly increase the understanding of these

IFN gene regulation: a brief introduction

Transcriptional activation of the IFN-β gene requires assembly of a multiprotein complex, the enhanceosome, which consists of activating transcription factor (ATF)2 and c-Jun, IRF3 and NF-κB [14]. This review focuses primarily on IRF3 and related family members. In resting cells, IRF3 resides in the cytoplasm [15]. Virus infection results in its signal-dependent phosphorylation, dimerization and interaction with the co-activator proteins CBP and p300 16, 17. This IRF3-containing complex then

TRIF-dependent IRF3 signaling

Our best understanding of IFN gene regulation comes from studies on TLR3 and TLR4 signaling. Lipopolysaccharide (LPS), via TLR4, triggers the nuclear translocation and DNA binding of IRF3 [25] and subsequent induction of IFN-β and IFN-stimulated genes 26, 27. This IRF3 response is crucial for protection against endotoxic shock in vivo [28]. TLR3 signaling in response to the dsRNA mimetic polyinosinic–polycytidylic acid [poly (I-C)] can also activate IRF3 29, 30, 31, a process mediated solely by

IFN gene induction in pDCs

Neither TLR3 nor TLR4 are expressed on pDCs; therefore, these pathways cannot account for the vast production of IFN in these cells. TLR expression by human and mouse pDCs is restricted to TLR7 and TLR9 [43], making them highly specialized for the detection of viral nucleic acids. As a consequence, they produce large quantities of IFN-α and IFN-β in response to purified ligands, including imidazoquinolines [44] and ssRNA 5, 45, for TLR7 5, 45, 46 or CpG oligonucleotides (CpG-ODNs), as well as

IRF7: the master regulator of IFN responses

Another key paper by Honda et al. [12] has highlighted the importance of IRF7 in the control of IFN-α and IFN-β subtypes. Using mice deficient in IRF7, the authors have shown that IRF7 is essential for the induction of IFN-α and -β genes via the MyD88-dependent TLR7 and 9 pathway. IRF7-deficient pDCs fail to induce IFN-α and IFN-β in response to purified TLR ligands, such as CpG-ODNs, ssRNA or HSV-1. Consistent with the earlier in vitro studies by Schoenemeyer et al. [51], Honda et al. [52] and

Distinct and essential roles of IRF5 in innate immune signaling

In contrast to IRF3 and IRF7, which are activated by most viruses, the activation of IRF5 seems to be much more restricted [70]. Only certain viruses, including Newcastle disease virus (NDV), VSV and HSV, have been shown to activate IRF5, whereas others such as SV or dsRNA [poly (I-C)], which activate IRF3 and IRF7, do not activate IRF5 [71]. These observations suggest that IRF5 is activated by signaling mechanisms distinct from those acting on IRF3. Schoenemeyer et al. [51] have shown that,

Importance of TLRs in antiviral defense in vivo

Although it is clear that TLR3, TLR7, TLR8 and TLR9 recognize nucleic acid structures to elicit a type I IFN-α and IFN-β response, particularly in pDCs in vitro, the relevance of TLRs in the in vivo response to virus infection is still in question. Findings from the studies by Krug et al. [49] and Hochrein et al. [74] were the first to show no major changes in morbidity or mortality when TLR7- or TLR9-deficient mice were infected with influenza or HSV in vivo. Although the TLR9–MyD88 pathway is

TLR-independent IFN gene induction: discovery of RNA helicases

Because the relevance of TLRs in the in vivo response to infection is unclear, the search for additional antiviral sensors has found considerable momentum. There is now overwhelming evidence to support the idea that cytoplasmic PRRs exist which sense virus infection. Various groups have indicated the importance of TLR-independent pathways in regulating antiviral responses in vivo 45, 46, 47, 49, 74, 78, 82. The double-stranded RNA-activated protein kinase R (PKR) was the first of such

Concluding remarks

The understanding of innate antiviral immunity has increased dramatically as a result of the discoveries discussed herein. However, many unanswered questions remain (Box 1). The key outstanding issues relate to how the two disparate sensing systems signal to IFN genes, and the functional importance of both systems in vivo. Continued interest in these crucial issues will probably add to this understanding. Defining these mechanisms in great detail will be important for enabling the design of

Acknowledgements

We thank Simon Rothenfusser, Nadege Goutagny, Egil Lien and Neal Silvermann for critically reading the manuscript.

References (89)

  • A. Schoenemeyer

    The interferon regulatory factor, IRF5, is a central mediator of toll-like receptor 7 signaling

    J. Biol. Chem.

    (2005)
  • A. Kanayama

    TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains

    Mol. Cell

    (2004)
  • L. Deng

    Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain

    Cell

    (2000)
  • L. Sun

    The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes

    Mol. Cell

    (2004)
  • A. Caillaud

    Regulatory serine residues mediate phosphorylation-dependent and phosphorylation-independent activation of interferon regulatory factor 7

    J. Biol. Chem.

    (2005)
  • M. Kerkmann

    Spontaneous formation of nucleic acid-based nanoparticles is responsible for high interferon-alpha induction by CpG-A in plasmacytoid dendritic cells

    J. Biol. Chem.

    (2005)
  • M.E. Mancl

    Two discrete promoters regulate the alternatively spliced human interferon regulatory factor-5 isoforms: multiple isoforms with distinct cell type-specific expression, localization, regulation, and function

    J. Biol. Chem.

    (2005)
  • K.H. Edelmann

    Does Toll-like receptor 3 play a biological role in virus infections?

    Virology

    (2004)
  • Y. Cui

    The Stat3/5 locus encodes novel endoplasmic reticulum and helicase-like proteins that are preferentially expressed in normal and neoplastic mammary tissue

    Genomics

    (2001)
  • A.N. Theofilopoulos

    Type I interferons (α/β) in immunity and autoimmunity

    Annu. Rev. Immunol.

    (2005)
  • T.H. Mogensen et al.

    Molecular pathways in virus-induced cytokine production

    Microbiol. Mol. Biol. Rev.

    (2001)
  • L. Alexopoulou

    Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3

    Nature

    (2001)
  • S.S. Diebold

    Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA

    Science

    (2004)
  • F. Heil

    Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8

    Science

    (2004)
  • H. Hemmi

    A Toll-like receptor recognizes bacterial DNA

    Nature

    (2000)
  • M. Yoneyama

    The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses

    Nat. Immunol.

    (2004)
  • J. Andrejeva

    The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter

    Proc. Natl. Acad. Sci. U. S. A.

    (2004)
  • B.R. Williams

    Signal integration via PKR

    Sci. STKE

    (2001)
  • M.G. Katze

    Viruses and interferon: a fight for supremacy

    Nat. Rev. Immunol.

    (2002)
  • K. Honda

    IRF-7 is the master regulator of type-I interferon-dependent immune responses

    Nature

    (2005)
  • A. Takaoka

    Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors

    Nature

    (2005)
  • T. Maniatis

    Mechanisms of human beta-interferon gene regulation

    Harvey Lect.

    (1986)
  • W.C. Au

    Identification of a member of the interferon regulatory factor family that binds to the interferon-stimulated response element and activates expression of interferon-induced genes

    Proc. Natl. Acad. Sci. U. S. A.

    (1995)
  • M. Yoneyama

    Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300

    EMBO J.

    (1998)
  • M. Yoneyama

    Control of IRF-3 activation by phosphorylation

    J. Interferon Cytokine Res.

    (2002)
  • I. Marie

    Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7

    EMBO J.

    (1998)
  • M. Colonna

    Plasmacytoid dendritic cells in immunity

    Nat. Immunol.

    (2004)
  • A. Izaguirre

    Comparative analysis of IRF and IFN-alpha expression in human plasmacytoid and monocyte-derived dendritic cells

    J. Leukoc. Biol.

    (2003)
  • E.M. Coccia

    Viral infection and Toll-like receptor agonists induce a differential expression of type I and lambda interferons in human plasmacytoid and monocyte-derived dendritic cells

    Eur. J. Immunol.

    (2004)
  • V. Toshchakov

    TLR4, but not TLR2, mediates IFN-beta-induced STAT1alpha/beta-dependent gene expression in macrophages

    Nat. Immunol.

    (2002)
  • T. Kawai

    Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes

    J. Immunol.

    (2001)
  • H. Oshiumi

    TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction

    Nat. Immunol.

    (2003)
  • M. Yamamoto

    Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling

    J. Immunol.

    (2002)
  • K.A. Fitzgerald

    LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF

    J. Exp. Med.

    (2003)
  • Cited by (28)

    • Toll-like receptor signalling as a cannabinoid target in Multiple Sclerosis

      2017, Neuropharmacology
      Citation Excerpt :

      Exogenous IFN-β is a current front-line therapy for MS, displaying beneficial effects on disability progression and relapse rate. Efficient production of IFN-β is orchestrated by TLRs, specifically, TLRs 3, 7, 8 and 9 localised on endosomal compartments where they recognise double stranded (ds)RNA, single stranded (ss)RNA and dsDNA (Jefferies and Fitzgerald, 2005). Importantly, data from the EAE model indicates that the signalling machinery regulating IFN-β expression is a pivotal player in the development of murine EAE.

    • Interferon induction by avian reovirus

      2016, Virology
      Citation Excerpt :

      For this, cells contain a series of endosomal and cytosolic sensors, called pattern recognition receptors (PRRs), which recognize pathogen associated molecular patterns (PAMPs), such as viral nucleic acids or viral intermediate products. When contacting PAMPs, PRRs become activated and transmit intracellular signaling pathways, culminating in the activation of specific transcription factors that translocate to the nucleus to stimulate type I IFN promoters (reviewed in Diebold (2010), Edwards et al. (2007), Jefferies and Fitzgerald (2005), Koyama et al. (2008) and Yoneyama and Fujita (2010)). Newly-synthesized type I IFNs are secreted out of the cell to interact with the ubiquitously expressed IFNAR receptor complex present in neighboring cells.

    • Oleanolic acid and ursolic acid: Novel hepatitis C virus antivirals that inhibit NS5B activity

      2013, Antiviral Research
      Citation Excerpt :

      As shown Fig. 8B, both oleanolic acid and ursolic acid showed no inducing effect on interferon-β transcription in HepG2 cells. In contrast, poly(I:C), as a positive control (Jefferies and Fitzgerald, 2005), significantly induced interferon-β mRNA in tested doses. Chronic HCV infection remains a serious burden on public health worldwide; however, there are no protective HCV vaccines and effective broad-spectrum antiviral therapies available for all genotypes of HCV, which prompted medical researchers around the world to identify novel and effective antiviral agents (Assis and Lim, 2012).

    • Role of Toll-Like Receptors in Respiratory Diseases

      2010, Archivos de Bronconeumologia
    • The intestinal epithelial barrier: How to distinguish between the microbial flora and pathogens

      2007, Seminars in Immunology
      Citation Excerpt :

      While the second part of the pathway was already well described (downstream of IFNARs), until recently, it remained unclear how microbial sensing resulted in IFN-α and IFN-β induction. Several recent reports have now provided a better understanding of how microbes trigger type I interferons (for a recent review, see Ref. [136]). The common feature is the phosphorylation and dimerization of IRF3, which then translocates to the nucleus, where it turns on IFN-α and IFN-β.

    View all citing articles on Scopus
    View full text